Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Mereo BioPharma Group (MREO) stocks in Canada
Learn how to easily invest in Mereo BioPharma Group stocks.
Mereo BioPharma Group is a biotechnology business based in the US. Mereo BioPharma Group stocks (MREO.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $3.15 – a decrease of 11.89% over the previous week. Mereo BioPharma Group employs 38 staff and has a trailing 12-month revenue of around $36.5 million.
How to buy shares in Mereo BioPharma Group
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – MREO – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in Mereo BioPharma Group?
- Has coronavirus impacted Mereo BioPharma Group shares?
- Mereo BioPharma Group shares summary
- Compare share dealing platforms
- Is Mereo BioPharma Group stock a buy or sell?
- Mereo BioPharma Group performance over time
- Mereo BioPharma Group's financials
- How volatile are Mereo BioPharma Group shares?
- Does Mereo BioPharma Group pay a dividend?
- Other common questions
Mereo BioPharma Group stock price (NASDAQ:MREO)Use our graph to track the performance of MREO stocks over time.
Mereo BioPharma Group shares at a glance
|Latest market close||$1.26|
|52-week range||$1.27 - $4.71|
|50-day moving average||$1.78|
|200-day moving average||$2.60|
|Wall St. target price||$699.23|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.36|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Mereo BioPharma Group stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Mereo BioPharma Group price performance over time
|1 week (2022-01-14)||-11.89%|
|1 month (2021-12-17)||-26.32%|
|3 months (2021-10-17)||N/A|
|6 months (2021-07-21)||-55.32%|
|1 year (2021-01-21)||-60.38%|
|2 years (2020-01-21)||-41.94%|
|3 years (2019-01-17)||N/A|
|5 years (2017-01-17)||N/A|
Mereo BioPharma Group financials
|Revenue TTM||$36.5 million|
|Gross profit TTM||$0|
|Return on assets TTM||-10.35%|
|Return on equity TTM||-51.32%|
|Market capitalisation||$155.7 million|
TTM: trailing 12 months
Mereo BioPharma Group share dividends
We're not expecting Mereo BioPharma Group to pay a dividend over the next 12 months.
Mereo BioPharma Group share price volatility
Over the last 12 months, Mereo BioPharma Group's shares have ranged in value from as little as $1.27 up to $4.711. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Mereo BioPharma Group's is 1.4419. This would suggest that Mereo BioPharma Group's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Mereo BioPharma Group overview
Mereo BioPharma Group plc, a biopharmaceutical company, acquires, develops, and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the treatment of tumor. The company is also developing Navicixizumab (OMP-305B83), which has completed Phase 1b clinical trials for the treatment of the late line ovarian cancer; Acumapimod (BCT-197), a p38 MAP kinase inhibitor that is in Phase II clinical trials to treat acute exacerbations of chronic obstructive pulmonary disease; and Leflutrozole (BGS-649), an oral aromatase inhibitor for the treatment of hypogonadotropic hypogonadism. In addition, it develops rare disease product candidates, including Setrusumab (BPS-804), a novel antibody for the treatment of osteogenesis imperfecta; and Alvelestat (MPH-966), an oral small molecule that is in Phase II clinical trial to treat Alpha-1 antitrypsin deficiency. The company has a collaboration with The University of Texas MD Anderson Cancer Center to evaluate anti-TIGIT therapeutic antibody candidate, etigilimab. Mereo BioPharma Group plc was founded in 2015 and is based in London, the United Kingdom. .
Mereo BioPharma Group in the news
Microsoft's $68.7 billion deal for Activision once again shows big tech's dominance over legacy media
Supreme Court vaccine mandate ruling won't bar companies from demanding Covid shots for workers — Biden vows to advocate for that
Do Hedge Funds Love Mereo BioPharma Group plc (MREO)?
Frequently asked questions
More guides on Finder
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
COVID testing stocks
We’ve rounded up stats on some of the most popular COVID testing stocks, along with information on how they compare and how to invest.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.
Pendle (PENDLE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Pendle, lists some exchanges where you can get it and provides daily price data on PENDLE.
Hempcoin (THC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Hempcoin, lists some exchanges where you can get it and provides daily price data on THC.
The ChampCoin (TCC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy The ChampCoin, lists some exchanges where you can get it and provides daily price data on TCC.